{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:45:18Z","timestamp":1783529118301,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:00:00Z","timestamp":1705795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","award":["XJTU1AF-CRF-2020-015"],"award-info":[{"award-number":["XJTU1AF-CRF-2020-015"]}],"id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","award":["XTU1AF2021CRF-003"],"award-info":[{"award-number":["XTU1AF2021CRF-003"]}],"id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.neurot.2024.e00327","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T18:10:57Z","timestamp":1707156657000},"page":"e00327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The relationship between atrial cardiopathy biomarkers and prognosis of patients with acute ischemic stroke after endovascular treatment"],"prefix":"10.1016","volume":"21","author":[{"given":"Yixin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuye","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guogang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neurot.2024.e00327_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrcardio.2016.106","article-title":"Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy","volume":"13","author":"Calenda","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00327_bib2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jacc.2017.06.033","article-title":"Atrial cardiomyopathy: a useful notion in cardiac disease management or a passing fad?","volume":"70","author":"Guichard","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00327_bib3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00327_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCRESAHA.120.316363","article-title":"Molecular basis of atrial fibrillation pathophysiology and therapy: a translational perspective","volume":"127","author":"Nattel","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.neurot.2024.e00327_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejim.2022.03.007","article-title":"Atrial cardiomyopathy: pathophysiology and clinical implications","volume":"101","author":"Tufano","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"21","key":"10.1016\/j.neurot.2024.e00327_bib6","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.neurot.2024.e00327_bib7","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00327_bib8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","article-title":"Atrial fibrillation and mechanisms of stroke: time for a new model","volume":"47","author":"Kamel","year":"2016","journal-title":"Stroke"},{"issue":"26","key":"10.1016\/j.neurot.2024.e00327_bib9","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00327_bib10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00327_bib11","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1212\/WNL.0000000000006748","article-title":"Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies","volume":"92","author":"Jalini","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00327_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1747493018799981","article-title":"The AtRial Cardiopathy and Antithrombotic Drugs in prevention after cryptogenic stroke randomized trial: rationale and methods","volume":"14","author":"Kamel","year":"2019","journal-title":"Int J Stroke"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00327_bib13","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.05.036","article-title":"PR interval prolongation and cryptogenic stroke: a multicenter retrospective study","volume":"26","author":"Montalvo","year":"2017","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00327_bib14","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1161\/STROKEAHA.114.006364","article-title":"P-wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis","volume":"45","author":"Kamel","year":"2014","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00327_bib15","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/STROKEAHA.114.004712","article-title":"N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort","volume":"45","author":"Cushman","year":"2014","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00327_bib16","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/STROKEAHA.117.020059","article-title":"Atrial cardiopathy and the risk of ischemic stroke in the CHS (cardiovascular Health study)","volume":"49","author":"Kamel","year":"2018","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00327_bib17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamaneurol.2021.1101","article-title":"Assessment of recurrent stroke risk in patients with a carotid web","volume":"78","author":"Guglielmi","year":"2021","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00327_bib18","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/STROKEAHA.109.575373","article-title":"Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study","volume":"41","author":"Marnane","year":"2010","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00327_bib19","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00327_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/neurintsurg-2013-010665","article-title":"2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials","volume":"6","author":"Goyal","year":"2014","journal-title":"J\u00a0Neurointerventional Surg"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00327_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00327_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/STROKEAHA.112.675942","article-title":"Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy","volume":"44","author":"Longstreth","year":"2013","journal-title":"Stroke"},{"issue":"13","key":"10.1016\/j.neurot.2024.e00327_bib23","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00327_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1747-4949.2012.00781.x","article-title":"Cerebral edema in acute ischemic stroke patients treated with intravenous thrombolysis","volume":"8","author":"Strbian","year":"2013","journal-title":"Int J Stroke"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00327_bib25","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/STROKEAHA.120.029494","article-title":"Predictors of unexplained early neurological deterioration after endovascular treatment for acute ischemic stroke","volume":"51","author":"Girot","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2024.e00327_bib26","doi-asserted-by":"crossref","first-page":"i1981","DOI":"10.1136\/bmj.i1981","article-title":"Sparse data bias: a problem hiding in plain sight","volume":"352","author":"Greenland","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.neurot.2024.e00327_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.903778","article-title":"Markers of atrial cardiopathy in severe embolic strokes of undetermined source","volume":"9","author":"Acampa","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.neurot.2024.e00327_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.982926","article-title":"Atrial cardiopathy is associated with cerebral microbleeds in ischemic stroke patients","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00327_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur J Echocardiogr"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00327_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/1747493016650454","article-title":"Early neurological deterioration after thrombolysis: clinical and imaging predictors","volume":"11","author":"Simonsen","year":"2016","journal-title":"Int J Stroke"},{"key":"10.1016\/j.neurot.2024.e00327_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.674612","article-title":"Atrial cardiomyopathy: an emerging cause of the embolic stroke of undetermined source","volume":"8","author":"Ning","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.neurot.2024.e00327_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2019.05.012","article-title":"Atrial fibrillation, not atrial cardiopathy, is associated with stroke: a single center retrospective study","volume":"402","author":"Affan","year":"2019","journal-title":"J\u00a0Neurol Sci"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00327_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1253\/circj.CJ-15-0138","article-title":"Role of inflammation in atrial fibrillation pathophysiology and management","volume":"79","author":"Harada","year":"2015","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00327_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","article-title":"Embolic stroke of undetermined source: a systematic review and clinical update","volume":"48","author":"Hart","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2024.e00327_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.829361","article-title":"The relationship between atrial cardiopathy biomarkers and prognosis of patients with embolic stroke of undetermined source","volume":"9","author":"Ning","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00327_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00327_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2217\/fca.15.22","article-title":"Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation","volume":"11","author":"Kamel","year":"2015","journal-title":"Future Cardiol"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00327_bib38","article-title":"Atrial cardiopathy in the absence of atrial fibrillation increases risk of ischemic stroke, incident atrial fibrillation, and mortality and improves stroke risk prediction","volume":"9","author":"Edwards","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00327_bib39","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/STROKEAHA.111.000173","article-title":"Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study","volume":"44","author":"Folsom","year":"2013","journal-title":"Stroke"},{"issue":"25","key":"10.1016\/j.neurot.2024.e00327_bib40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00327_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12872-017-0632-0","article-title":"Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure","volume":"17","author":"Khanam","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00327_bib42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/svn-2020-000440","article-title":"Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies","volume":"6","author":"Zhang","year":"2021","journal-title":"Stroke Vasc Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00327_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/STROKEAHA.120.029593","article-title":"Early NT-ProBNP (N-terminal probrain natriuretic peptide) elevation predicts malignant edema and death after reperfusion therapy in acute ischemic stroke patients","volume":"52","author":"Zhang","year":"2021","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00327_bib44","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/STROKEAHA.117.017226","article-title":"Abnormal P-wave Axis and ischemic stroke: the ARIC study (atherosclerosis risk in communities)","volume":"48","author":"Maheshwari","year":"2017","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00327_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105086","article-title":"Electrocardiographic left atrial abnormality in patients presenting with ischemic stroke","volume":"29","author":"Kwon","year":"2020","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00327_bib46","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.24482","article-title":"Electrocardiographic left atrial abnormality and stroke subtype in\u00a0the\u00a0atherosclerosis risk in communities study","volume":"78","author":"Kamel","year":"2015","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00327_bib47","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1161\/STROKEAHA.115.009989","article-title":"Electrocardiographic left atrial abnormality and risk of stroke: northern manhattan study","volume":"46","author":"Kamel","year":"2015","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00327_bib48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000512179","article-title":"Association of electrocardiographic P-wave markers and atrial fibrillation in embolic stroke of undetermined source","volume":"50","author":"Li","year":"2021","journal-title":"Cerebrovasc Dis"}],"updated-by":[{"DOI":"10.1016\/j.neurot.2024.e00361","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000}}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T13:45:04Z","timestamp":1711201504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924000138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1878747924000138"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00327","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.neurot.2024.e00361","asserted-by":"object"}]},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between atrial cardiopathy biomarkers and prognosis of patients with acute ischemic stroke after endovascular treatment","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00327"}}